+91 85276 09083
MANO-M
As per a trial, treatment with Mano-M as a FDC of voglibose and metformin in Type 2 diabetes, it provided superior glycemic control for HbA1c, 2h-PPG, and FPG levels, greater in weight loss, and less glycemic variability. Composition: Each uncoated bilayer tablet contains: Voglibose IP 0.3 mg Metformin Hydrochloride IP 500 mg (as sustained release)
